Staff Member, Medical Oncology Department Antoni Van Leeuwenhoek-Netherlands Cancer Institute Amsterdam, The Netherlands
Carolien Schröder, MD, PhD, is a medical oncologist with a focus on breast cancer at the Netherlands Cancer Institute (AVL-NKI) Amsterdam, and the University Medical Center Groningen (UMCG), the Netherlands. Her research emphasis is on exploring novel rational treatment options to enhance therapeutic efficacy and personalized medicine in interdisciplinary, translational research. This has led to research regarding pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases, early clinical trials with novel anticancer agents, as well as large scale registration and translational trials for rare subgroups including male and inflammatory breast cancer. It has also led to preclinical and clinical molecular imaging studies, with regard to visualization of tumor specific targets including cancer drug targets. She was research fellow Fox Chase Cancer Center, Philadelphia, and Dana-Farber Cancer Center in Boston, MA. Dr. Schröder is involved in national breast cancer guideline development and is a member of an international research consortia regarding male breast cancer and inflammatory breast cancer. She is currently supervising 6 PhD students and has published over 125 scientific publications including 25 publications as first or senior author. Since 2008, she received a total budget of 5 million euro from different institutions (including Dutch Cancer Society, Dutch Pink Ribbon Foundation) as main applicant and 11,6 million euro as co-applicant.